Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.72 |
| ▸ | NT5E | P21589 | 1/20 | 0.72 |
| ▸ | CA2 | P00918 | 5/20 | 0.66 |
| ▸ | CA12 | O43570 | 4/20 | 0.66 |
| ▸ | CA9 | Q16790 | 4/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.50 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.49 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11590196 | 1.00 | TSHR (0.72) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL5752505 | 0.98 | TSHR (0.75) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL1485997 | 0.98 | TSHR (0.75) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL28543329 | 0.96 | TSHR (0.72) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL18624977 | 0.87 | POLB (0.83) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL28560987 | 0.87 | POLB (0.83) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL646074 | 0.87 | TSHR (0.95) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL7766917 | 0.87 | TSHR (0.95) | TSHRALDH1A1NT5ECA2CA12 | |
| Water SCHEMBL2045998 | 0.85 | TSHR (0.90) | TSHRALDH1A1NT5ECA2CA12 | |
| SCHEMBL28275690 | 0.85 | TSHR (0.90) | TSHRALDH1A1NT5ECA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111187408-A | Method for synthesizing polyamino acid with photoresponse characteristic | 金陵科技学院 | 2020-05-22 | — | — | CN | claimed |
| EP-1515144-B2 | METHOD OF ASSAY WITH SULFONIC ACID COMPOUND AND NITRO COMPOUND | ARKRAY INC (JP) | 2013-04-24 | — | — | EP | claimed |
| US-8021855-B2 | Method of decomposing protein with sulfonic acid compound | ARKRAY INC. (JP) | 2011-09-20 | — | — | US | claimed |
| EP-1515144-B1 | METHOD OF ASSAY WITH SULFONIC ACID COMPOUND AND NITRO COMPOUND | ARKRAY INC (JP) | 2009-10-14 | — | — | EP | claimed |
| US-7354732-B2 | Method of assay with sulfonic acid compound and nitro compound | ARKRAY, INC. (JP) | 2008-04-08 | — | — | US | claimed |
| US-20050260735-A1 | Method of decomposing protein with sulfonic acid compound | ARKRAY, INC. (JP) | 2005-11-24 | — | — | US | claimed |
| US-20050221415-A1 | Method of assay with sulfonic acid compound and nitro compound | ARKRAY, INC. (JP) | 2005-10-06 | — | — | US | claimed |
| EP-1522593-A1 | METHOD OF DECOMPOSING PROTEIN WITH SULFONIC ACID COMPOUND | ARKRAY, Inc. (JP) | 2005-04-13 | — | — | EP | claimed |
| EP-1515144-A1 | METHOD OF ASSAY WITH SULFONIC ACID COMPOUND AND NITRO COMPOUND | ARKRAY, Inc. (JP) | 2005-03-16 | — | — | EP | claimed |
| JP-4293969-A | — | — | None | — | — | JP | disclosed |
| US-20250221408-A1 | COMPOSITION | EARTH CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| EP-3550030-B1 | METHOD FOR MEASURING GLYCATION RATE OF HEMOGLOBIN | TOYO BOSEKI (JP) | 2025-01-01 | — | — | EP | disclosed |
| EP-4473837-A1 | COMPOSITION | Earth Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | ACENET INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| EP-1522593-A1 | METHOD OF DECOMPOSING PROTEIN WITH SULFONIC ACID COMPOUND | ARKRAY, Inc. (JP) | 2005-04-13 | — | — | EP | disclosed |
| EP-1515144-A1 | METHOD OF ASSAY WITH SULFONIC ACID COMPOUND AND NITRO COMPOUND | ARKRAY, Inc. (JP) | 2005-03-16 | — | — | EP | disclosed |
| US-20020192247-A1 | Thermochromic/photochromic cosmetic compositions | THEISEN LYLE (US) | 2002-12-19 | — | — | US | disclosed |
| JP-H04293969-A | LIQUID COMPOSITION OF DIRECT DYE | NIPPON KAYAKU CO LTD | 1992-10-19 | — | — | JP | disclosed |
| US-4227879-A | ISOLATING THE DIAZONIUM SALT OF P-(P-AMINOPHENYL)AZO BENZENESULFONIC ACID AND COUPLING WITH 6-AMINO-1-NAPHTHOL-3-SULFONIC ACID | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1980-10-14 | — | — | US | disclosed |
| US-4082742-A | PROCESS FOR PREPARING AN AQUEOUS DISAZO DYE CONCENTRATE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | EIF2AK2, HAO2, ZC3HAV1 | TSHR 461/4885ALDH1A1 1641/4885NT5E 3141/4885 |
| US-20250221408-A1 | COMPOSITION | GGPS1, PGGT1B, HBG2 | TSHR 4073/4885ALDH1A1 1071/4885NT5E 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.